Yasmin and Yaz Lawsuits FAQ
Why are lawsuits being filed against the manufacturer of Yaz and Yasmin?
According to studies published by the British Medical Journal (BMJ), patients who use the birth control pills Yaz and Yasmin are twice as likely to experience blood clots as users of another birth control brand. Patients who took Yaz or Yasmin and suffered blood clots or other cardiovascular side effects have alleged that they were not properly warned about the risk of side effects before taking the birth control pills.
How many Yasmin and Yaz lawsuits have already been filed?
According to a July 2012 newsletter released by Bayer Pharmaceuticals, the manufacturer of Yaz and Yasmin, more than 12,000 lawsuits regarding the birth control pills have already been filed against the company. Lawyers for Bayer have stated that they expect even more lawsuits to be filed by patients who developed blood clots or other cardiovascular problems after taking Yaz or Yasmin.
Have any class action lawsuits been filed during the Yasmin and Yaz litigation?
According to Bayer’s February 2012 statement, at least three class action lawsuits involving Yaz or Yasmin have been filed against the company in the US. Bayer also revealed that 13 Yasmin or Yaz class action lawsuits had been filed against the company in Canada.
Have any of these lawsuits reached a settlement?
As of July 2012, Bayer had paid more than $402 million to settle nearly 1,900 lawsuits filed by users of Yaz or Yasmin. Despite these settlements, thousands of claims by former Yaz or Yasmin patients still remain pending against Bayer.
Am I eligible to file a lawsuit against Yaz or Yasmin?
If you or a loved one used Yaz, Yasmin or other birth control pills containing drospirenone and developed blood clots or other related conditions, you may be eligible to file a lawsuit. For a free legal consultation to find out if you qualify, contact the lawyers at Hissey Kientz, LLP by calling toll-free at 1-866-275-4454, or by filling out the free case evaluation form located on this page.